Mouse Anti-ALAD Recombinant Antibody (V2-180593) (CBMAB-A2129-YC)

Name: Mouse Anti-ALAD Recombinant Antibody (V2-180593)
SKU: CBMAB-A2129-YC
Rating: 5 (1 reviews)

See all ALAD antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

V2-180593

Application

WB, ICC, IHC-P, C, ELISA

Immunogen

Aminolevulinate Delta Dehydratase

Host Species

Mouse

Specificity

Rat

Antibody Isotype

IgG

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Application	Note
WB	0.2-2 µg/ml
IF(ICC)	5-20 µg/ml
IHC	5-20 µg/ml

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

PBS, pH 7.4, 50% glycerol

Preservative

0.02% sodium azide

Concentration

1 mg/ml

Storage

Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Aminolevulinate Dehydratase

Introduction

The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin a

Entrez Gene ID

25374

UniProt ID

P06214

Alternative Names

Aminolevulinate Dehydratase; Porphobilinogen Synthase; Aminolevulinate, Delta-, Dehydratase; EC 4.2.1.24; ALADH; Delta-Aminolevulinic Acid Dehydratase; Testicular Tissue Protein Li 95; PBGS;

Function

Catalyzes an early step in the biosynthesis of tetrapyrroles. Binds two molecules of 5-aminolevulinate per subunit, each at a distinct site, and catalyzes their condensation to form porphobilinogen.

Biological Process

Cellular response to interleukin-4 Source: Ensembl
Cellular response to lead ion Source: Ensembl
Heme biosynthetic process Source: UniProtKB
Negative regulation of proteasomal protein catabolic process Source: CAFA
Neutrophil degranulation Source: Reactome
Protein homooligomerization Source: UniProtKB
Protoporphyrinogen IX biosynthetic process Source: UniProtKB-UniPathway
Response to activity Source: Ensembl
Response to aluminum ion Source: Ensembl
Response to amino acid Source: Ensembl
Response to arsenic-containing substance Source: Ensembl
Response to cadmium ion Source: Ensembl
Response to cobalt ion Source: Ensembl
Response to drug Source: Ensembl
Response to ethanol Source: Ensembl
Response to fatty acid Source: Ensembl
Response to glucocorticoid Source: Ensembl
Response to herbicide Source: Ensembl
Response to hypoxia Source: Ensembl
Response to ionizing radiation Source: Ensembl
Response to iron ion Source: Ensembl
Response to lipopolysaccharide Source: Ensembl
Response to mercury ion Source: Ensembl
Response to methylmercury Source: Ensembl
Response to oxidative stress Source: Ensembl
Response to platinum ion Source: Ensembl
Response to selenium ion Source: Ensembl
Response to vitamin B1 Source: Ensembl
Response to vitamin E Source: Ensembl
Response to zinc ion Source: Ensembl

Cellular Location

Cytosol; Extracellular exosome; Extracellular region; Nucleus; Ficolin-1-rich granule lumen; Secretory granule lumen

Involvement in disease

Acute hepatic porphyria (AHEPP): A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AHP is characterized by attacks of gastrointestinal disturbances, abdominal colic, paralyses and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors.

Yohannes, Y. B., Nakayama, S. M., Yabe, J., Toyomaki, H., Kataba, A., Nakata, H., ... & Ishizuka, M. (2021). Delta-aminolevulinic acid dehydratase (ALAD) and vitamin D receptor (VDR) genes polymorphisms in children residing in an abandoned lead‑zinc mine area in Kabwe, Zambia. Meta Gene, 27, 100838.

Bah, H. A., Dos Anjos, A. L. S., Gomes-Júnior, E. A., Bandeira, M. J., de Carvalho, C. F., Dos Santos, N. R., ... & Menezes-Filho, J. A. (2021). Delta-Aminolevulinic Acid Dehydratase, Low Blood Lead Levels, Social Factors, and Intellectual Function in an Afro-Brazilian Children Community. Biological Trace Element Research, 1-11.

Hamid, O. I. A., Khayal, E. E. S. H., Tolba, S. A. R., & Orabi, E. E. (2020). Maternal Δ-aminolevulinic acid dehydratase 1-2 genotype enhances fetal lead exposure and increases the susceptibility to the development of cerebral palsy. Environmental Science and Pollution Research, 27(36), 44709-44723.

Saliu, J. A., Ademiluyi, A. O., Boligon, A. A., Oboh, G., Schetinger, M. R. C., & Rocha, J. B. T. (2019). Dietary supplementation of jute leaf (Corchorus olitorius) modulates hepatic delta‐aminolevulinic acid dehydratase (δ‐ALAD) activity and oxidative status in high‐fat fed/low streptozotocin‐induced diabetic rats. Journal of food biochemistry, 43(8), e12949.

Neeleman, R. A., van Beers, E. J., Friesema, E. C., Koole‐Lesuis, R., van der Pol, W. L., Wilson, J. P., & Langendonk, J. G. (2019). Clinical Remission of Delta‐Aminolevulinic Acid Dehydratase Deficiency Through Suppression of Erythroid Heme Synthesis. Hepatology (Baltimore, Md.), 70(1), 434.

Mani, M. S., Kunnathully, V., Rao, C., Kabekkodu, S. P., Joshi, M. B., & D’Souza, H. S. (2018). Modifying effects of δ-Aminolevulinate dehydratase polymorphism on blood lead levels and ALAD activity. Toxicology letters, 295, 351-356.

Ge, J., Yu, Y., Xin, F., Yang, Z. J., Zhao, H. M., Wang, X., ... & Cao, X. C. (2017). Downregulation of delta‐aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer. Cancer science, 108(4), 604-611.

La-Llave-León, O., Méndez-Hernández, E. M., Castellanos-Juárez, F. X., Esquivel-Rodríguez, E., Vázquez-Alaniz, F., Sandoval-Carrillo, A., ... & Salas-Pacheco, J. M. (2017). Association between blood lead levels and delta-aminolevulinic acid dehydratase in pregnant women. International journal of environmental research and public health, 14(4), 432.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-ALAD Recombinant Antibody (V2-180593)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-ALAD Recombinant Antibody (V2-180592) (CAT#: CBMAB-A2128-YC)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry